7 Followers on Owler
OverviewCompetitorsFundingNews & Insights

vTv Therapeutics Competitors or Alternatives

vTv Therapeutics's top competitors include AstraZeneca, Lilly and Lexicon.

Unlock 11 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

vTv Therapeutics's company profile

Paul Sekhri

President & CEO

84/100
9
$231.2M
$1M
  • $231.2M
    $1M
  • 9
    $231.2M
  • $1M
  • 84/100
  • 9
  • $231.2M
  • $1M
View ProfileView
1
vTv Therapeutics's Competitor - AstraZeneca logo

Pascal Soriot

CEO

72/100
89,900
$100M
$51.2B
  • $100M
    $51.2B
  • 89,900
    $100M
  • $51.2B
  • 72/100
  • 89,900
  • $100M
  • $51.2B
View ProfileView
2
vTv Therapeutics's Competitor - Lilly logo

David A. Ricks

Chairman & CEO

80/100
39,000
- -
$45B
  • - -
    $45B
  • 39,000
    - -
  • $45B
  • 80/100
  • 39,000
  • - -
  • $45B
View ProfileView
3
vTv Therapeutics's Competitor - Lexicon logo

Mike Exton

CEO

83/100
140
$760.3M
$31.1M
  • $760.3M
    $31.1M
  • 140
    $760.3M
  • $31.1M
  • 83/100
  • 140
  • $760.3M
  • $31.1M
View ProfileView
4
vTv Therapeutics's Competitor - PharmaCyte Biotech logo

Joshua N. Silverman

Interim-CEO

82/100
4
$87.1M
$ < 1M
  • $87.1M
    $ < 1M
  • 4
    $87.1M
  • $ < 1M
  • 82/100
  • 4
  • $87.1M
  • $ < 1M
View ProfileView
5
vTv Therapeutics's Competitor - ViaCyte logo

Michael J. Yang

President & CEO

84/100
100 - 250
$220.7M
$25M - 100M
  • $220.7M
    $25M - 100M
  • 100 - 250
    $220.7M
  • $25M - 100M
  • 84/100
  • 100 - 250
  • $220.7M
  • $25M - 100M
View ProfileView
vTv Therapeutics' top 14 competitors are AstraZeneca, Lilly, Lexicon, Arcutis, PharmaCyte Biotech, ViaCyte, ARMO BioSciences, NGM Bio, Lixte, SCYNEXIS, Petra Pharma, Athenex, NexImmune and VelosBio. Together they have raised over 4.2B between their estimated 129.9K employees. vTv Therapeutics has 9 employees and is ranked 12th among it's top 10 competitors. The top 10 competitors average 8,658.

vTv Therapeutics VS AstraZeneca

AstraZeneca is the biggest rival of vTv Therapeutics. AstraZeneca is headquartered in Cambridge, England, and was founded in 1999. Like vTv Therapeutics, AstraZeneca also operates in the Biotechnology space. AstraZeneca generates 5,035,004% the revenue of vTv Therapeutics.

vTv Therapeutics VS Lilly

Lilly is vTv Therapeutics's #2 competitor. Lilly is a Public company that was founded in Indianapolis, Massachusetts in 1876. Like vTv Therapeutics, Lilly also works within the Pharmaceuticals & Biotechnology sector. Lilly has 38,991 more employees vs. vTv Therapeutics.

vTv Therapeutics VS Lexicon

Lexicon has been one of vTv Therapeutics's top competitors. Lexicon's headquarters is in The Woodlands, Texas, and was founded in 1995. Lexicon operates in the Pharmaceuticals industry. Lexicon generates 3,056% of vTv Therapeutics's revenue.

Looking for similar companies to vTv Therapeutics?

Similar Companies

Biotechnology companies in Piedmont Triad

See 36 companies 
Biotechnology companies in North Carolina

See 363 companies 
Pharmaceuticals & Biotechnology companies in Piedmont Triad

See 52 companies 
Pharmaceuticals & Biotechnology companies in North Carolina

See 641 companies 
Companies in High Point with revenue in $5.0-25M range

See 663 companies 
Companies in High Point with employees in 25-100 range

See 810 companies 
Biotechnology companies with revenue in $5.0-25M range

See 3,620 companies 
Biotechnology companies with employees in 25-100 range

See 5,169 companies 
Pharmaceuticals & Biotechnology companies with revenue in $5.0-25M range

See 5,525 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for vTv Therapeutics and vTv Therapeutics's Competitors

April 17, 2025StreetInsider
Orforglipron is the first small molecule GLP-1 to successfully complete a Phase 3 trial, lowering A1C by an average of 1.3% to 1.6% across......
April 17, 2025Openpr
The global strep throat treatment market was valued at US$ 2.08 Bn in 2025 and is expected to reach US$ 2.85 Bn by 2032, growing at a compound annual g...
April 17, 2025centralcharts
WESTLAKE VILLAGE, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company...

Frequently Asked Questions about vTv Therapeutics

  1. Who are vTv Therapeutics's top competitors?

    vTv Therapeutics's top 3 competitors are AstraZeneca, Lilly, Lexicon.

  2. Who is similar to vTv Therapeutics?

    AstraZeneca is the most similar to vTv Therapeutics. Lilly and Lexicon are also similar to vTv Therapeutics.

  1. Are vTv Therapeutics and AstraZeneca competitors?

    Yes, AstraZeneca is one of vTv Therapeutics’s top competitors.